148 related articles for article (PubMed ID: 21151177)
1. Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease.
Plante I; Stewart MK; Barr K; Allan AL; Laird DW
Oncogene; 2011 Apr; 30(14):1681-92. PubMed ID: 21151177
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of connexin43 gap junctions is an independent marker for breast tumors.
Laird DW; Fistouris P; Batist G; Alpert L; Huynh HT; Carystinos GD; Alaoui-Jamali MA
Cancer Res; 1999 Aug; 59(16):4104-10. PubMed ID: 10463615
[TBL] [Abstract][Full Text] [Related]
3. Milk secretion and ejection are impaired in the mammary gland of mice harboring a Cx43 mutant while expression and localization of tight and adherens junction proteins remain unchanged.
Plante I; Wallis A; Shao Q; Laird DW
Biol Reprod; 2010 May; 82(5):837-47. PubMed ID: 20089884
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43.
Avanzo JL; Mesnil M; Hernandez-Blazquez FJ; Mackowiak II; Mori CM; da Silva TC; Oloris SC; Gárate AP; Massironi SM; Yamasaki H; Dagli ML
Carcinogenesis; 2004 Oct; 25(10):1973-82. PubMed ID: 15166089
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
Crowley MR; Frost A; Chen DT; Baffi MO; Nicola T; Serra R
Differentiation; 2006 Feb; 74(1):40-52. PubMed ID: 16466399
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of connexin43 result in impaired development of the mammary gland in a mouse model of oculodentodigital dysplasia.
Plante I; Laird DW
Dev Biol; 2008 Jun; 318(2):312-22. PubMed ID: 18455714
[TBL] [Abstract][Full Text] [Related]
7. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
[TBL] [Abstract][Full Text] [Related]
9. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
Nesterova MV; Cho-Chung YS
Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
[TBL] [Abstract][Full Text] [Related]
10. Fate of connexin43 in cardiac tissue harbouring a disease-linked connexin43 mutant.
Manias JL; Plante I; Gong XQ; Shao Q; Churko J; Bai D; Laird DW
Cardiovasc Res; 2008 Dec; 80(3):385-95. PubMed ID: 18678643
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo.
Krutovskikh VA; Troyanovsky SM; Piccoli C; Tsuda H; Asamoto M; Yamasaki H
Oncogene; 2000 Jan; 19(4):505-13. PubMed ID: 10698520
[TBL] [Abstract][Full Text] [Related]
12. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors.
Budunova IV; Carbajal S; Viaje A; Slaga TJ
Mol Carcinog; 1996 Mar; 15(3):190-201. PubMed ID: 8597532
[TBL] [Abstract][Full Text] [Related]
13. The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.
Tomblyn S; Langenheim JF; Jacquemart IC; Holle E; Chen WY
Int J Oncol; 2005 Nov; 27(5):1381-9. PubMed ID: 16211235
[TBL] [Abstract][Full Text] [Related]
14. Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer.
Blanco-Aparicio C; Pérez-Gallego L; Pequeño B; Leal JF; Renner O; Carnero A
Carcinogenesis; 2007 Mar; 28(3):584-94. PubMed ID: 17050554
[TBL] [Abstract][Full Text] [Related]
15. The G60S Cx43 mutant enhances keratinocyte proliferation and differentiation.
Churko JM; Kelly JJ; Macdonald A; Lee J; Sampson J; Bai D; Laird DW
Exp Dermatol; 2012 Aug; 21(8):612-8. PubMed ID: 22775996
[TBL] [Abstract][Full Text] [Related]
16. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S
Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608
[TBL] [Abstract][Full Text] [Related]
17. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
18. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice.
Murphy KL; Kittrell FS; Gay JP; Jäger R; Medina D; Rosen JM
Oncogene; 1999 Nov; 18(47):6597-604. PubMed ID: 10597264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
